Abies pindrow Royle (Himalayan Silver Fir; Pinaceae) has been traditionally used for the treatment for anxiety but the plant has not been systematically investigated to validate its traditional claims. Thus, it was planned to investigate antianxiety activity of various extracts and fractions of A. pindrow aerial parts using elevated plus maze model (EPM). Properly identified A. pindrow aerial parts were successively and exhaustively extracted using solvents in increasing order of polarity viz., n-hexane, chloroform, methanol and water. All crude extracts were subjected to antianxiety activity at the doses of 100, 200 or 400 mg/kg, p.o. in mice. Efficacy of A. pindrow was statistically compared with the standard anxiolytic drug, diazepam (2 mg/kg, i.p.). Amongst various extracts, chloroform and methanol extract exhibited significant antianxiety activity with respect to control, and statistically equivalent to the standard drug at the dose of 200 and 400 mg/kg, respectively. The bioactive methanol extract was partitioned successively using solvents in increasing order of polarity viz., n-hexane, ethyl acetate and 1-butanol. All fractions were also subjected to antianxiety activity at the doses of 25 or 50 mg/kg, p.o. in mice. Only ethyl acetate fraction (EAF) exhibited significant antianxiety activity equivalent to the standard drug at the dose 50 mg/kg. Present studies scientifically validated traditional claims of A. pindrow for antianxiety activity. Flavonoids of A. pindrow aerial parts have been suggested to play role in treating anxiety disorders.
INTRODUCTION
Global scenario of persons afflicted by mental disorders is alarming.
1 About 500 million people suffer from neurotic, stress related and somatoform problems, 200 million from mood disorders, 83 million from mental retardation, 30 million from epilepsy, 22 million from dementia, and 16 million from schizophrenia. Anxiety disorders are serious medical illnesses that have affected 1 /8 th of total population worldwide irrespective of gender, age, religion, nationality and profession. 2 Anxiety Disorders Association of America (ADAA) described anxiety disorders as the most common mental illness in the US that have affected 19.1 million (13.3%) of the adult (18-54 years) US population. 3 In India, prevalence rate for all mental disorders is 65.4 per 1000 population, and that for anxi- ety neurosis is 18.5 per 1000 population. 4 The Global Research on Anxiety and O fauna is so vast that the Indian scientists are investigating plants, based on their use in traditional system of medicine, for the treatment of neurological disorders. Abies pindrow Royle (Himalayan Silver Fir; Pinaceae) is a plant which has long tradition of use in the treatment of anxiety.
7 It is widely distributed at elevations between 2000-3000 m throughout the Western Himalayas from Afghanistan to Nepal. 8, 9 have suggested role of A. pindrow aerial parts in treating anxiety disorders, but uncharacterized crude extracts of A. pindrow aerial parts have been employed in this pharmacological investigation. 9 Therefore, systematic research is needed on A. pindrow aerial parts to validate traditional claims especially for anxiety disorders. Present research work reported by the authors is different from previous study as: (a) various extracts of A. pindrow aerial parts have been prepared successively for evaluation of antianxiety activity; (b) fractionation of bioactive extract has been done to purify crude extract; (c) specific class of phytoconstituents responsible for activities and their probable modes of action have been suggested.
MATERIALS AND METHODS

Collection and identification of plant material
Abies pindrow aerial parts were collected form Gulaba Kothi, Manali at a height of 2000-2100 m, India in September, 2012. Identity of the plant was confirmed by Dr 
Preparation of extracts and fractions
A. pindrow aerial parts were dried under sunlight and powdered in a grinder. Dried powdered plant material (2 kg) was extracted in a Soxhlet apparatus successively using solvents in increasing order of polarity viz., n-hexane, chloroform and methanol. Water extract was prepared by boiling the marc of plant material with distilled water for 2 h on a hot plate. Solvents and water from crude extracts were recovered under reduced pressure using rotary vacuum evaporator (BUCHI, Switzerland) to get n-hexane extract (HE), chloroform extract (CE), methanol extract (ME) and water extract (WE). The bioactive extract (100 g) of plant material was suspended uniformly in water, placed in a round bottom flask, and partitioned successively using solvents in increasing order of polarity viz., n-hexane, ethyl acetate and 1-butanol by heating at 50ºC for 30 min along with continuous stirring. This procedure of partitioning with each solvent was repeated eight more times. All the separated layers of every solvent were pooled and concentrated under reduced pressure to get n-hexane fraction (HF), ethyl acetate fraction (EAF), 1-butanol fraction (BF) and remaining bioactive extract (RBE). Various extracts and fractions were subjected to phytochemical screening to ascertain various classes of phytoconstituents present therein. Mice were acclimatized to laboratory conditions by housing them daily in the laboratory for 1 h for seven consecutive days before the start of experiment. All the experiments were carried between 9 AM to 12 PM as per the guidelines of Committee for the Purpose of Control and Supervision on Experiments on Animals. Mice were fasted overnight before use. Test drugs were administered orally with the help of an oral cannula fitted on a tuberculin syringe.
Vehicle and standard drug
Distilled water + Tween 80 (2%) was used as vehicle for preparing various test doses of various extracts, fractions and isolates in such a concentration as to administer a volume ranging 0.2 to 0.25 ml to the mice. Diazepam (Triko Pharmaceuticals, Rohtak, Haryana) was used as standard antianxiety drug at a dose of 2 mg/kg, i.p.
Experimental design
Two experimental protocols were designed. A total of 24 groups of mice were made, and each group comprised 6 mice. Experimental protocol I, comprising groups I to XIV, was designed to assess antianxiety activity of crude extracts of A. pindrow aerial parts.
• Group I -Control, received vehicle (0.25 ml, p.o.).
• Group II -Standard, received diazepam (2 mg/ kg, i.p.).
• Groups III to V -Test, received 100, 200 or 400 mg/kg doses of HE respectively.
• Groups VI to VIII -Test, received 100, 200 or 400 mg/kg doses of CE respectively.
• Groups IX and XI -Test, received 100, 200 or 400 mg/kg doses of ME respectively.
• Groups XII and XIV -Test, received 100, 200 or 400 mg/kg doses of WE respectively.
Experimental protocol II, comprising groups I to X, was designed to assess antianxiety activity of various fractions obtained from bioactive extract of A. pindrow aerial parts.
• Groups III and IV -Test, received 25 or 50 mg/ kg doses of HF respectively.
• Groups V and VI -Test, received 25 or 50 mg/ kg doses of EAF respectively.
• Groups VII and VIII -Test, received 25 or 50 mg/kg doses of BF respectively.
• Groups IX and X -Test, received 25 or 50 mg/ kg doses of RBE respectively. 
Statistics
The results have been expressed as mean ± standard deviation (SD). The test drugs were compared with standard drug and control by one way analysis of variance (ANOVA) followed by Student Newman Keul's test. 12 
RESULTS
Yields of HE, CE, ME and WE were found to be 3.20, 4.10, 10.60 and 16.10%, respectively. All extracts were screened for different classes of phytoconstituents. The results of phytochemical screening showed presence of lipids in HE; triterpenoids in CE; triterpenoids, steroids, flavonoids, carbohydrates and proteins in ME; tannins, saponins, carbohydrates and proteins in water extract. All extracts of A. pindrow aerial parts were subjected to antianxiety activity screening in mice using EPM. Table 1 shows the mean number of entries and mean time spent in open arms of EPM by mice after administration of 100, 200 or 400 mg/kg, doses of crude extracts, diazepam (2 mg/kg) and vehicle. Amongst various extracts, CE and ME exhibited significant antianxiety activity with respect to control. HE and WE were found to be devoid of antianxiety activity. Though, 200 or 400 mg/kg doses of ME significantly increased number of entries and time spent in open arms in mice with respect to control, but statistically equivalent anxiolytic activity to the standard drug was observed only at the dose of 400 mg/kg. Mice treated with CE (200 or 400 mg/kg) showed significant increase in number of entries and time spent in open arms of EPM in comparison to the control group, and the activity was equivalent to the standard group. The bioactive methanol extract was further fractionated using solvents in increasing order of polarity viz., n-hexane, ethyl acetate and 1-butanol. Yields of HF, EAF, BF and RBE were found to be 6.89, 18.66, 14.76 and 55.49%, respectively. Phytochemical screening of various fractions showed presence of steroids in HF; flavonoids and triterpenoids in EAF. Various fractions of bioactive extract were subjected to antianxiety activity screening in mice using EPM. Table 2 shows the mean number of entries and mean time spent in open arms of EPM by mice after administration of 25 or 50 mg/kg, doses of fractions, diazepam (2 mg/kg) or vehicle. Amongst various fractions, only EAF exhibited significant antianxiety activity at the dose of 50 mg/kg with respect to control, and the activity was equivalent to the standard drug. HF and RBE were devoid of antianxiety activity. Although, the antianxiety activity of BF was statistically insignificant with respect to the standard group, yet it was statistically significant with respect to the control group. This observation confirms mild antianxiety activity of BF.
DISCUSSION
Anti-anxiety activity of various extracts/fractions of A. pindrow aerial parts was evaluated using well established model, i.e., EPM. The model was chosen since it is effective, cheap, simple, less time consuming, and requires no preliminary training to the mice and does not cause much discomfort to the animals while handling. 13 The ultimate manifestation of anxiety due to height in the animals is exhibited by decrease in motor activity, which is measured by number of entries and average time spent in the open arms of EPM by the mice.
14 Various extracts of A. pindrow aerial parts were evaluated for antianxiety activity. Amongst various extracts, chloroform and methanol extract exhibited significant antianxiety activity with respect to control and equivalent to the standard drug at the dose level of 200 and 400 mg/kg, respectively. Therefore, bioactive methanol extract was fractionated using standardized procedure to get HF, EAF and BF. All fractions were also subjected to antianxiety activity screening at doses of 25 or 50 mg/kg, p.o. in mice. Only EAF exhibited significant antianxiety activity which was equivalent to the standard drug diazepam at the dose 50 mg/kg whereas BF exhibited mild antianxiety activity at the dose of 50 mg/kg.
It is suggested that the antianxiety activity of extracts and fractions of A. pindrow aerial parts could be attributed to inhibition of γ-amino butyric acid transmission, 15 binding to benzodiazepine receptors as agonist, 16 or their ability to increase ascorbic acid level in brain 17 and monoamine oxidase inhibition. 18 Preliminary phytochemical studies showed presence of flavonoids and triterpenoids in bioactive extracts / fractions of A. pindrow aerial parts.
Our results are in agreement with the reported literature where flavonoids -quercetin, 18 kaempferol 19 and apigenin; 20 and triterpenoids -galphimine A, galphimine B 21 and α, β-amyrin 22 have been reported to exhibit anxiolytic activity. It is finally suggested that flavonoids and / or triterpenoids are responsible for anxiolytic activity of A. pindrow aerial parts. Detailed investigations are in progress to isolate bioactive constituent(s) from bioac- tive methanol extract and EAF of A. pindrow aerial parts following antianxiety activity-guided fractionation.
